Literature DB >> 2770269

Effects of arginine and ornithine on strength, lean body mass and urinary hydroxyproline in adult males.

R P Elam, D H Hardin, R A Sutton, L Hagen.   

Abstract

Twenty-two adult males participated in a 5 week progressive strength training program. One half the subjects received the amino acids L-arginine and L-ornithine and the other half, a placebo. The study used a double blind protocol so that subjects as well as investigators had no knowledge of which substances were being administered. Dosages amounted to 2 grams or 1 gram each of L-arginine and L-ornithine, and 600 mg of calcium and 1 gram of Vitamin C as placebos. These supplements were taken orally for a total of 25 administrations. Following the short term strength program using progressively high intensities, tests were taken for total strength (TS), lean body mass (LBM) and urinary hydroxyproline (UH). The results from ANOVA showed that subjects who were taking the arginine-ornithine combination scored significantly higher in TS and LBM (p less than .05), and significantly lower in UH (p less than .05), than subjects on placebos. It was concluded that arginine and ornithine taken in prescribed doses can, in conjunction with a high intensity strength training program, increase TS and LBM in a relatively short period of time. Arginine and ornithine also aid in recovery from chronic stress by quelling tissue breakdown as evidenced by lower UH levels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2770269

Source DB:  PubMed          Journal:  J Sports Med Phys Fitness        ISSN: 0022-4707            Impact factor:   1.637


  8 in total

1.  Biotransformation of L-ornithine from L-arginine using whole-cell recombinant arginase.

Authors:  Yueping Zhan; Junzhong Liu; Pingting Mao; Hongjuan Zhang; Qian Liu; Qingcai Jiao
Journal:  World J Microbiol Biotechnol       Date:  2013-05-23       Impact factor: 3.312

2.  The effect of l-arginine supplementation on body composition and performance in male athletes: a double-blinded randomized clinical trial.

Authors:  N Pahlavani; M H Entezari; M Nasiri; A Miri; M Rezaie; M Bagheri-Bidakhavidi; O Sadeghi
Journal:  Eur J Clin Nutr       Date:  2017-01-25       Impact factor: 4.016

Review 3.  Amino acid supplementation and exercise performance. Analysis of the proposed ergogenic value.

Authors:  R B Kreider; V Miriel; E Bertun
Journal:  Sports Med       Date:  1993-09       Impact factor: 11.136

4.  L-Arginine supplementation does not enhance blood flow and muscle performance in healthy and physically active older women.

Authors:  Andreo Fernando Aguiar; Mario Carlos Welin Balvedi; Cosme Franklim Buzzachera; Leandro Ricardo Altimari; Marcell Alysson Batisti Lozovoy; Marcelo Bigliassi; Renata Selvatici Borges Januário; Rafael Mendes Pereira; Vanda Cristina Sanches; Douglas Kratki da Silva; Guilherme Atsushi Muraoka
Journal:  Eur J Nutr       Date:  2015-08-18       Impact factor: 5.614

5.  Arginine and antioxidant supplement on performance in elderly male cyclists: a randomized controlled trial.

Authors:  Steve Chen; Woosong Kim; Susanne M Henning; Catherine L Carpenter; Zhaoping Li
Journal:  J Int Soc Sports Nutr       Date:  2010-03-23       Impact factor: 5.150

6.  Acute L-arginine alpha ketoglutarate supplementation fails to improve muscular performance in resistance trained and untrained men.

Authors:  Benjamin Wax; Andreas N Kavazis; Heather E Webb; Stanley P Brown
Journal:  J Int Soc Sports Nutr       Date:  2012-04-17       Impact factor: 5.150

7.  L-arginine intake effect on adenine nucleotide metabolism in rat parenchymal and reproductive tissues.

Authors:  G Kocic; J Nikolic; T Jevtovic-Stoimenov; D Sokolovic; H Kocic; T Cvetkovic; D Pavlovic; A Cencic; D Stojanovic
Journal:  ScientificWorldJournal       Date:  2012-04-24

8.  L-arginine supplementation and risk factors of cardiovascular diseases in healthy men: a double-blind randomized clinical trial.

Authors:  Naseh Pahlavani; Mostafa Jafari; Omid Sadeghi; Masoud Rezaei; Hamid Rasad; Hossein Ali Rahdar; Mohammad Hasan Entezari
Journal:  F1000Res       Date:  2014-12-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.